Home › Orexigen's Contrave Sales Recover - Investors Should Look To Europe
 

Keywords :   


Orexigen's Contrave Sales Recover - Investors Should Look To Europe

2015-02-19 12:27:30| Biotech - Topix.net

Contrave, the anti-obesity pill from Orexigen saw sales increase by 10% this past week. Contrave sold just above 8,400 scripts for its best week to date.

Tags: to sales europe investors

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11Natracare Launches E-Commerce Site
04.11Tropical Depression Eighteen Graphics
04.11The Honey Pot Launches Witch Hazel Intimate Wash & Wipes
04.11Remnants of Patty Graphics
04.11Tropical Depression Eighteen Forecast Discussion Number 4
More »